Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended
CIK 1890904 · last filed 2022-04-04
Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for BTTX, was dated Apr 4, 2022. Across all open-market trades the lifetime net is +$9.8K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
1
$9.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Better Therapeutics, Inc. (BTTX) Delisted | 10%+ Owner | 2,412,969 | $0.04 | $107.6K | $9.8K | 1 | 2022-04-04 |
Recent Filings
1 filing| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-04 | Better Therapeutics, Inc. (BTTX) Delisted | Mixed | +5,000 | $9.8K | EDGAR |